Status:
RECRUITING
International Validation of Two Non-motor Scales in PD (NFS and SPARK)
Lead Sponsor:
Insel Gruppe AG, University Hospital Bern
Collaborating Sponsors:
Michael J. Fox Foundation for Parkinson's Research
Carlos III Health Institute
Conditions:
Parkinson's Disease
Non-motor Symptoms
Eligibility:
All Genders
30-75 years
Brief Summary
The goal of this project is to develop the international validation of two new rating scales, the Neuropsychiatric Fluctuations Scale (NFS) and the Shame in PARKinson's disease (SPARK) Scale, in order...
Detailed Description
This project is a prospective international multicentre study to validate two new rating scales in different languages: the Neuropsychiatric Fluctuations Scale (NFS) and the Shame in PARKinson's disea...
Eligibility Criteria
Inclusion
- Written informed consent;
- PD, according to the MDS criteria;
- Age of participants \> 30 and \< 75 years;
- Being fluent in the language in which the scales are applied.
Exclusion
- 1\. Presence of PD dementia (defined as MoCA score \< 24).
Key Trial Info
Start Date :
December 3 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04366804
Start Date
December 3 2020
End Date
December 31 2025
Last Update
April 13 2025
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre hospitalier régional universitaire de Besançon
Besançon, France, 25000
2
Universitätsklinikum Carl Gustav Carus
Dresden, Germany, 01307
3
Aristotle University of Thessaloniki
Thessaloniki, Greece, 541 24
4
Transilvania University
Brasov, Romania, 500036